期刊文献+

Studies on in vitro release of cyclosporine A-loaded microspheres 被引量:1

环孢素A微球的体外释放影响因素(英文)
下载PDF
导出
摘要 Aim This study was to prepare cyclosporine A (CyA) microspheres (Ms) using 75:25 poly (D, L-lactide-co-glycolide) polymer (PLGA), and to evaluate the in vitro release of the CyA microspheres. Methods CyA-Ms were prepared by an oil-inwater (o/w) emulsion solvent extraction/evaporation process and characterized for drug content, particle size, surface morphology, and differential scanning calorimeter (DSC). Accelerated in vitro release of cyclosporine A from the mieropsheres was studied at various conditions, such as temperatures, surfactants, pH values and organic solvents for a short period. Results CyA-Ms were in spherical shape with average particle size of 50 μm and loading efficiency of 13.0%. The results of DSC measurements suggested that at the dry state, CyA did interact very strongly with the hydrophilic PLGA polymer. In vitro release test in various release medium showed slight increase of CyA-Ms release profiles under various conditions of temperatures, surfactants and pH values. However, dramatical increase of CyA-Ms release was seen in the medium containing 30% isopropanol. Conclusion It was demonstrated that CyA could be incorporated into polymeric Ms prepared from PLGA using a solvent evaporation technique. The release medium containing 30% isopropanol might be the ideal condition for CyA-PLGA microspheres in vitro quality control test. 目的以环孢素A为模型药,使用生物可降解材料乳酸/羟基乙酸PLGA制备微球。并评价微球的体外释放。方法使用乳化溶剂挥发法制备环孢素微球,并对微球的外观,粒径和载药量进行评价。通过衡量温度,pH值和表面活性剂等因素筛选体外释放介质。结果制得的微球外观圆整,粒径统一,平均粒径50μm左右,载药量为13%。DSC结果表明环孢素A和PLGA有结合作用。体外释放实验表明微球的释放受温度,pH值和表面活性剂的影响,加入30%的异丙醇可使微球在2周内释放完全。结论乳化溶剂挥发法可制备得到质量符合要求的环孢素微球,含30%异丙醇的释放介质是微球体外释放评价的理想介质。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2007年第4期252-256,共5页 中国药学(英文版)
基金 Science and Technology Program of Beijing(Grant No. D0205003040621).
关键词 Cyclosporine A (CyA) Mierospheres (Ms) PLGA In vitro release 环孢素A(CyA) 微球(Ms) PLGA 体外释放
  • 相关文献

参考文献11

  • 1Mohammed Shameem,Heeyong Lee,Patrick P. DeLuca.A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations[J].AAPS PharmSci.1999(3)
  • 2Gritz, D.C,Wong I.G. Ophthalmology . 2004
  • 3Zimmer, A,Kreuter, J. Adv. Drug Deliv. Rev . 1995
  • 4Kim, S J,Choi, H.K.,Suh, S.P.,Lee, Y.B. Eur. J. Pharm. Sci . 2002
  • 5Heya, T,Okada, H.,Ogawa, Y.,Toguchi, H. Int. J. Pharm . 1991
  • 6Bodmer, D,Kissel, T.,Traechslin, E. J. Controlled Release . 1992
  • 7Park T.G,Lu, W.,Crotts, G. J. Controlled Release . 1995
  • 8Yang, J,Cleland, J. J. Pharm. Sci . 1997
  • 9Johansen, P,Corradin, G.,Merkle, H.P.,Gander, B. J. Controlled Release . 1998
  • 10Russel, G.J,Jeffery, H. Control. Rel. Bioact. Mater . 1994

同被引文献26

  • 1左六一,解新,赵语,王晓江.环孢素A滴眼液的研制[J].重庆医科大学学报,2004,29(5):696-698. 被引量:3
  • 2高雅,孙考祥,齐艳华.环孢素脂质体滴眼液在兔眼组织的吸收[J].哈尔滨医科大学学报,2005,39(1):67-69. 被引量:3
  • 3周晓洁,张秀华,黄学荪,刘萌.环孢素A滴眼液的制备及质量控制[J].中国医院药学杂志,2005,25(6):574-575. 被引量:3
  • 4Chast F, Lemare F, Legeais JM, et al.Cyclosporine 2% eye drops preparation[J]. J Fr Ophthalmol, 2004, 27(6): 567-576.
  • 5Di Napoli G. Ophthalmic formulations[P].US Patent, 6953776.2005-10-11.
  • 6Kuwano M, Ibuki H, Morikawa N, et al. Cyclosporine A formulation affects its ocular distribution in rabbits[J]. Pharm Res, 2002,19(1) : 108.
  • 7Sanson J, Barnett KC, Neumann W, et al. Treatment of keratoconjunctivitis sicca in dogs with cyclosporine oph- thalmic ointment: a European clinical field trial[J]. Ve Ree, 1995.137(20::504.
  • 8毛宇锋.含有环孢素的眼用乳剂凝胶及其制备方法:中国,CN201210011033.7[P].2012-07-04.
  • 9甘勇,甘莉,马守伟,等.1种环孢菌素A眼用微/亚微乳原位凝胶制剂及其制备方法:中国,CN200710037662.6[P].2008-08-20.
  • 10赵彬然.载环孢素壳聚糖/海藻酸钙微球系统的研制及性能研究[D].西北大学,2010.http://cdmd.cnki.tom.cn/Article/CDMD-l0697.2010l19242.htm.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部